Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
about
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancerUnfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patientsEpidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgeryLow molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancerEpidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgeryEpidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgeryVenous thromboembolic diseasePrevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesPost-discharge complications after esophagectomy account for high readmission ratesElevated risk of venous thromboembolic events in patients with inflammatory myopathiesPrevention of venous thromboembolism in patients undergoing bariatric surgeryVenous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxisVenous thromboembolism in cancer patients: an underestimated major health problemIncidence and cost burden of post-thrombotic syndromeUnfractionated heparin: focus on a high-alert drug.Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide.[Prophylaxis and treatment of venous thromboembolism in cancer patients. Clinical value of low-molecular-weight heparins].Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons.Venous thromboembolism in cancer patients.Defining incidence and risk factors of venous thromboemolism after hepatectomy.The effect of a continuing medical education program on Venous thromboembolism prophylaxis utilization and mortality in a tertiary-care hospital.The potential benefits of low-molecular-weight heparins in cancer patientsCancer and venous thromboembolic disease: from molecular mechanisms to clinical management.Venous thromboembolism after surgery for benign prostatic hyperplasia.Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgeryReview of bemiparin sodium--a new second-generation low molecular weight heparin and its applications in venous thromboembolism.Epidemiology, risk factors and sequelae of venous thromboembolism.Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study.Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery.Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders.A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients.The rate and mortality of postoperative venous thromboembolism of moderate risk surgery in Asian patients without thrombo-prophylaxis: systematic review with meta-analysis.Low-molecular-weight heparins: are they all the same?From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer.Users' guide to the surgical literature: how to perform a literature search.Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.The effect of postoperative enoxaparin on risk for reoperative hematoma.Venous thromboembolism and malignancy.Venous Thromboembolism-Incidence of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Head and Neck Cancer: A Tertiary Care Experience in Pakistan
P2860
Q24193749-D96B6982-3259-45D5-8313-D82633DA8269Q24200589-6617EE6D-7355-4B9D-9663-7E18E2009F04Q24202136-31EDCBC6-88C5-4062-B276-E50801946721Q24235023-84DD37FE-34DA-4374-BFAE-A410E1108AF8Q24245538-1B2D15F1-A365-4A2B-A783-74381E536AA6Q24246958-7FD89AC8-5D1E-4C0D-89F2-FE22B0E3C8BAQ24631121-E8EA40D5-3E0A-4706-BB7D-152DE0D47D64Q24632902-FE615D9C-A280-41FA-B73C-439128405C71Q24632982-9C0B8616-2B93-4FEC-9FFA-FAD3087C86DAQ24658449-DFAE124A-EA04-4CAA-8D0B-C8DA83DEED8CQ26746904-CDB1A92D-0E55-4C22-9A87-12D2D5E40BFBQ26796429-3101A5EB-C4B3-4BF4-AFB9-47EE6786EB0EQ26797444-881A0103-3158-418F-B573-965181259296Q26852015-FDA8A6A8-FF99-46D6-8E55-A211FBCC1CC5Q28235459-AAE8205C-819A-42B6-8920-C0AE15D04E3CQ33362322-223DC822-9B43-472E-AAC4-0D33ECC3BA43Q33385947-A612476B-747C-4305-8E18-B8CBD9DABEFDQ33413690-802785C4-60D1-4AD3-9CF5-D63B7B421E8FQ33415676-0AA77FAF-49EA-4D3F-90F0-16E906A8BA66Q33419213-865C9B6B-4859-4013-BE56-75BCE5F1029CQ33650840-BE72B801-D7D0-4ACF-AB9D-FC66BFDB1D34Q33698200-F55F9D2F-49D6-4EDA-9948-02E2B7B2DBF7Q33698360-D45179C1-ABEB-4252-835B-6F7D066CC0FBQ33763866-E4E2757D-5200-47A4-970E-F43454CF28F6Q33906746-0BC74004-99BA-40C1-AD6C-DB5BBD701D84Q34211162-9896BDEF-AFA0-4F82-8BB3-4D29DDECCEEDQ34225846-953A9E1B-4B3E-4376-B693-9AF7751B6ECCQ34264218-A21E8D05-C02C-41FC-9ADD-E5F7BF5AD222Q34324192-EEA61789-6600-4360-A9AA-592700B1954DQ34423980-340663F2-2B54-45EB-A2FE-B327921BD68CQ34481810-DB460785-0F67-4EE2-97CB-138E5949C696Q34685478-02800F38-F910-41DE-9F41-9B99842313FDQ35010762-290FFE42-2123-49EE-904E-8B5F0E04AB7AQ35096649-D0FED876-9211-446C-8A14-5D0A4A40611EQ35181616-D1906C34-368D-4BD9-A7C5-D45663AFC6C7Q35537555-59B65A7F-AA70-4CBB-B2C7-0644470B051FQ35630940-5E9F321D-FEE2-4CE9-A8B0-04D3668AA1EBQ35634089-4C0E9645-779E-4BED-BBDE-670C8F785085Q35728779-583F21EC-7424-4702-8764-C61B3EE89C11Q35815447-E64C5BB1-7977-4556-B716-35E351BDE491
P2860
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Meta-analysis of low molecular ...... boembolism in general surgery.
@en
Meta-analysis of low molecular ...... boembolism in general surgery.
@nl
type
label
Meta-analysis of low molecular ...... boembolism in general surgery.
@en
Meta-analysis of low molecular ...... boembolism in general surgery.
@nl
prefLabel
Meta-analysis of low molecular ...... boembolism in general surgery.
@en
Meta-analysis of low molecular ...... boembolism in general surgery.
@nl
P2093
P2860
P1476
Meta-analysis of low molecular ...... boembolism in general surgery.
@en
P2093
Buchmüller A
Decousus H
Mismetti P
P2860
P304
P356
10.1046/J.0007-1323.2001.01800.X
P407
P577
2001-07-01T00:00:00Z